progenics

  1. T

    Progenics Announces Approvals Of New Ready-To-Use Pre-Filled Syringes For RELISTOR In

    Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced that the U.S. Food and Drug Administration (FDA), along with the European Medicines Agency (EMA) of the European Union (E.U.) and Health Canada, the Canadian Regulatory Agency, have each approved single-use, pre-filled syringes of...
Back
Top